A

Ascendis Pharma A/S

ASND

136.370
USD
2.93
(2.20%)
Market Closed
Volume
2,425
EPS
0
Div Yield
0
P/E
-14
Market Cap
7,708,029,469
Related Instruments
ADI
-12.280
(-5.31%)
219.020 USD
A
ALRM
-2.130
(-3.02%)
68.450 USD
E
ENTG
-8.390
(-7.09%)
109.890 USD
I
IPGP
-3.090
(-3.85%)
77.250 USD
MCHP
-4.260
(-4.80%)
84.560 USD
M
MPWR
-77.73
(-9.00%)
785.67 USD
SNPS
-17.12
(-3.07%)
540.65 USD
S
SWKS
-5.550
(-4.88%)
108.120 USD
TEL
-4.080
(-2.64%)
150.290 USD
T
TER
-9.360
(-7.13%)
121.840 USD
News

Title: Ascendis Pharma A/S

Sector: Healthcare
Industry: Biotechnology
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.